Confluent CRO sells 3,768 shares under 10b5-1

Confluent, Inc.’s Chief Revenue Officer, Ryan Mac Ban Norris, reported open-market sales of Class A common stock under a pre-arranged 10b5-1 trading plan dated August 22, 2025.

Rhea-AI Filing Summary

Confluent, Inc.’s Chief Revenue Officer, Ryan Mac Ban Norris, reported open-market sales of Class A common stock under a pre-arranged 10b5-1 trading plan dated August 22, 2025. He sold 1,655 shares at $30.54 on February 13, 2026 and 2,113 shares at $30.61 on February 18, 2026, totaling 3,768 shares.

After these transactions, he directly owned 390,163 shares of Confluent Class A common stock. This amount includes 1,398 shares acquired through the company’s employee stock purchase plan on February 13, 2026, indicating he retains a substantial equity position following the scheduled sales.

Insider Trade Summary

Net Seller: 3,768 shares

Net Sell 2 txns

Insider Mac Ban Ryan Norris

Role Chief Revenue Officer

Sold 3,768 shs ($115K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	2,113	$30.61	$65K
Sale	Class A Common Stock	1,655	$30.54	$51K

Holdings After Transaction: Class A Common Stock — 390,163 shares (Direct)

Footnotes (2)

1. F1. The shares were sold pursuant to a 10b5-1 plan dated August 22, 2025.
2. F2. Includes 1,398 shares purchased through the Issuer's employee stock purchase plan on February 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Confluent (CFLT) report for Ryan Mac Ban Norris?

Confluent’s Chief Revenue Officer, Ryan Mac Ban Norris, reported selling 3,768 shares of Class A common stock in open-market transactions under a 10b5-1 plan. The sales occurred on February 13 and 18, 2026, at prices slightly above $30 per share.

How many Confluent (CFLT) shares did the CRO sell and at what prices?

Ryan Mac Ban Norris sold 1,655 Confluent Class A shares at $30.54 on February 13, 2026, and 2,113 shares at $30.61 on February 18, 2026. In total, he sold 3,768 shares through these open-market transactions.

Was the Confluent (CFLT) insider sale by the CRO under a 10b5-1 plan?

Yes. The filing states the CRO’s share sales were made pursuant to a Rule 10b5-1 trading plan dated August 22, 2025. Such plans pre-schedule trades, helping insiders diversify holdings while reducing concerns about trading on material nonpublic information.

How many Confluent (CFLT) shares does the CRO own after these sales?

After the reported transactions, Ryan Mac Ban Norris directly owned 390,163 shares of Confluent Class A common stock. This total includes 1,398 shares purchased through Confluent’s employee stock purchase plan on February 13, 2026, showing continued equity ownership.

What role does Ryan Mac Ban Norris hold at Confluent (CFLT)?

Ryan Mac Ban Norris serves as Confluent’s Chief Revenue Officer. As a senior executive, his Form 4 filings disclose changes in his beneficial ownership of Confluent Class A common stock, including sales executed under pre-arranged 10b5-1 trading plans and shares acquired via employee programs.

Did the Confluent (CFLT) CRO acquire any shares around the time of these sales?

Yes. The filing notes his holdings include 1,398 Confluent shares purchased through the company’s employee stock purchase plan on February 13, 2026. These ESPP shares are part of his 390,163 total shares owned after the reported open-market sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mac Ban Ryan Norris

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVE.

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Revenue Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/13/2026		S		1,655(1)	D	$30.54	392,276(2)	D
Class A Common Stock	02/18/2026		S		2,113	D	$30.61	390,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold pursuant to a 10b5-1 plan dated August 22, 2025.

2. Includes 1,398 shares purchased through the Issuer's employee stock purchase plan on February 13, 2026.

	/s/ Weilyn Wood, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.